Acceptance criteria for levels of hydrazine in substances for pharmaceutical use and analytical methods for its determination.

Pharmeuropa scientific notes

Volumn 2006, Issue 2, 2006, Pages 23-33

  Kean, T ^a   Miller, J H McB ^a   Skellern, G G ^a   Snodin, D ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; HYDRAZINE; HYDRAZINE DERIVATIVE;

ANIMAL; ARTICLE; CHEMISTRY; DRUG CONTAMINATION; DRUG SURVEILLANCE PROGRAM; EUROPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MEDICAL LITERATURE; METHODOLOGY; PHARMACEUTICS; PILOT STUDY; QUALITY CONTROL; REPRODUCIBILITY; STANDARD; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, ION EXCHANGE; CHROMATOGRAPHY, THIN LAYER; DRUG CONTAMINATION; EUROPE; HUMANS; HYDRAZINES; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PHARMACEUTICAL PREPARATIONS; PHARMACOPOEIAS; PILOT PROJECTS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TECHNOLOGY, PHARMACEUTICAL; TOXICITY TESTS;

EID: 34548088383     PISSN: 18142435     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)